Mifepristone and Misoprostol Labor Induction in Intrauterine Fetal Demise: Meta-Analysis
ACOG ePoster. Kanninen T. Apr 27, 2018; 212091; 38Q
Tomi Kanninen
Tomi Kanninen
Login now to access Regular content available to all registered users.

You may also access this content "anytime, anywhere" with the Free MULTILEARNING App for iOS and Android
Abstract
Rate & Comment (0)
Introduction: Systematic review and meta-analysis was conducted to assess the effectiveness of combination mifepristone and misoprostol compared to misoprostol alone for induction of labor (IOL) for intrauterine fetal demise (IUFD) after 20 gestational weeks.

Methods: Medline, Scopus, ClinicalTrials.gov, Embase, Science Direct, Cochrane Central Register of Controlled Trials, and Scielo were searched for the following terms: “mifepristone”, “misoprostol”, and “IUFD” from inception until September 2017. All randomized controlled trials (RCTs) examining misoprostol versus the combination of misoprostol and mifepristone were included. Primary outcome was induction to delivery interval. Intragroup differences in parity, gestational age and bishop score was examined. Meta-analysis (Review Manager v.5.3) was performed using a fixed effects model to produce summary treatment effects in terms of mean difference, with 95% confidence intervals. Heterogeneity was measured using Chi-square and I2 statistics. GRADE approach was used to assess the quality of evidence.

Results: Two RCTs, including 140 women met inclusion criteria. The combination of mifepristone and misoprostol lead to a shorter interval to delivery mean difference -4.19 hours (95% CI, -5.58, -2.81). Chi-square 0.39, I2 =0%. There was no significant difference between groups in regard to parity, gestational age and bishop score. The quality of evidence was judged as low due to lack of clear randomization, allocation concealment, and blinding.

Conclusion/Implications: Combination mifepristone and misoprostol is effective and leads to a shorter induction to delivery interval as compared to misoprostol alone for IOL for IUFD after 20 gestational weeks. Further well-designed RCTs are necessary given the low quality of evidence.
    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.


Save Settings